Barely Significant
← all excerpts

L3MBTL2 as a novel therapeutic target for trigeminal neuralgia: evidence from integrated TWAS, multi-tissue MR, and experimental validation.

J Headache Pain · 2025 · PMC12696905 · PMID 41382013

Europe PMCDOI
1
hedged sentence
0.0022
closest p · 0.0× alpha
0.0022
boldest claim

The sentences

highly significantP = 0.0022actually significant
The exact test (analyzed with GraphPad Prism) revealed a highly significant reduction in L3MBTL2 expression in the CCI group compared to the Sham controls (U = 0, exact P = 0.0022).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.